In summary, we emphasize the cancer-specific nature of MMP9 and underscore the potential of N-glycosylation, particularly the potential acquisition of trimmed glycosignatures, to enhance patient stratification strategies in gastric cancer. The gene discussed is MMP9; the disease is cancer.